Cure8 news brief
High and rising out-of-pocket costs can force people with Crohn’s disease to worry about medical debt, skip care, or make major life changes. Policy choices about insurance coverage (like Medicaid expansion) can meaningfully change financial stress and access to care.
Adults with IBD (especially those on biologics), people who rely on employer-sponsored insurance, caregivers, patient advocates, and policy-makers focused on health coverage and affordability.
This is a first-person patient story about living with Crohn’s disease and the financial strain of managing care. It describes loss of employer coverage, high out-of-pocket costs, medical debt, and relief after gaining Medicaid expansion coverage in New York.
The piece names a biologic medication (Rinvoq) and gives monthly cost context; it does not present clinical data or research findings.
This is a single patient’s account published by Families USA, a health-policy advocacy organization. It illustrates real-world financial barriers but is not a clinical study. The article names a specific drug price and personal debt amounts reported by the subject.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Crohn’s can sometimes cause flare-ups or complications that make working difficult or impossible; disability benefits can replace part of lost income. The article lays out the types of benefits and what the SSA looks for...
Spanish-speaking people with Crohn’s disease or ulcerative colitis often face language and access barriers to care and information. A dedicated Spanish-language community can improve access to medically reviewed...
Racial and socioeconomic factors can delay Crohn’s diagnosis and limit access to specialist care, testing, and medications — which can lead to worse outcomes. Knowing these disparities can help patients, caregivers, and...
